AC Immune SA (ACIU)
3.25
+0.12
(+3.83%)
USD |
NASDAQ |
Dec 29, 16:00
3.19
-0.06
(-1.85%)
Pre-Market: 20:00
AC Immune Research and Development Expense (Quarterly): 16.33M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 505.41M |
| CRISPR Therapeutics AG | 54.50M |
| Addex Therapeutics Ltd. | 0.2853M |
| NewCelX Ltd. | -- |
| Molecular Partners AG | 10.41M |